良性甲状腺结节微波消融后体积缩小率预测因素荟萃分析
结果显示囊性结节、低回声结节及较小结节体积缩小率更优,而大结节治疗成功率降低。该结果为术前患者筛选提供了循证依据。
要点
- 囊性结节消融后体积缩小率显著优于实性结节,平均差20.38%。
- 结节越大治疗成功率越低,OR 0.25。
- 低回声结节疗效优于高回声结节,OR 0.34。
核心结论
- 结节成分、大小和回声是微波消融疗效的关键决定因素,囊性及低回声结节体积缩小率最佳,大结节降低治疗成功率。
研究设计与样本
- 系统综述与荟萃分析,检索PubMed、Web of Science、Embase、Cochrane Library和Scopus,检索截至2025年7月。
- 方法学质量采用Newcastle-Ottawa Scale评估,多数研究为高质量,平均NOS评分7.7/9。
关键影像表现/征象
- 囊性结节较实性结节消融后体积缩小率更高,平均差20.38%(95%CI 13.28%-27.48%)。
- 较大结节与手术成功率降低相关,OR 0.25(95%CI 0.14-0.43)。
- 高回声结节相较于低回声结节治疗成功率更低,OR 0.34(95%CI 0.21-0.56)。
- 年龄、性别、钙化、边缘及强化特征与体积缩小率无显著关联。
诊断标准与关键数值
- 囊性结节与实性结节体积缩小率平均差20.38%(95%CI 13.28%-27.48%)。
- 结节大小与手术成功率OR 0.25(95%CI 0.14-0.43)。
- 高回声与低回声结节成功率OR 0.34(95%CI 0.21-0.56)。
临床应用与阅片要点
- 消融前评估结节成分、大小和回声有助于筛选可能获益最大的患者。
- 囊性和低回声且体积较小的结节可优先考虑微波消融治疗。
- 高回声大结节应充分告知疗效可能受限,避免过度预期。
局限性
- 原文未报告研究设计局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Thyroid nodules represent a prevalent clinical condition, with the majority being benign. Microwave ablation (MWA) has emerged as a minimally invasive alternative to surgery, yet volume reduction rate (VRR) outcomes following MWA exhibit substantial heterogeneity. This meta-analysis aimed to identify multifactorial predictors of VRR in patients with benign thyroid nodules undergoing MWA. A systematic search was conducted across PubMed, Web of Science, Embase, Cochrane Library and Scopus from inception to July 2025. Sixteen studies involving 2321 patients met the inclusion criteria and reported VRR outcomes stratified by preprocedural characteristics. Pooled odds ratios (OR) and mean differences (MD) were calculated for binary and quantitative outcomes, respectively, with methodological quality assessed via Newcastle-Ottawa Scale (NOS). Cystic nodules showed significantly better treatment response than solid lesions (MD in VRR: 20.38%, 95% confidence intervals [CI]: 13.28%-27.48%). Larger nodule size was associated with reduced procedural success (OR 0.25, 95% CI 0.14-0.43), and hyperechoic nodules had lower success rates compared to hypoechoic ones (OR 0.34, 95% CI 0.21-0.56). No significant associations were observed for age, sex, calcification, margin or enhancement features. Most studies were high-quality (mean NOS score: 7.7/9). In conclusion, nodule composition, size and echogenicity are key MWA efficacy determinants, with cystic and hypoechoic nodules achieving optimal VRR, while large size reduces treatment success. These predictors facilitate evidence-based patient selection and underscore the need for standardized classification criteria.
引用
- Lin, Zhang, Liu, et al. Predictors of Volume Reduction Rate Following Microwave Ablation for Benign Thyroid Nodules: A Systematic Review and Meta-Analysis. Ultrasound Med Biol. 2026. PMID: 41580312. doi:10.1016/j.ultrasmedbio.2025.12.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。